Score Overview
Explore the 2021 public Archive ranking →
Where Abeona Therapeutics Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ABEO
2008: 99.1% · 2021: 97.9% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-22 | $ 4.47 | — |
1 Year2025-10-22 | $ 5.41 | -17.38% |
5 Years2021-10-22 | $ 21.50 | -79.21% |
10 Years2016-10-21 | $ 208.50 | -97.86% |
20 Years2006-10-20 | $ 1.38K | -99.67% |
30 Years1996-10-22 | $ 132.5K | -100.00% |
All Time1980-09-19 | $ 916.77K | -100.00% |
| Period | Last Price2026-10-22 | 1 Year2025-10-22 | 5 Years2021-10-22 | 10 Years2016-10-21 | 20 Years2006-10-20 | 30 Years1996-10-22 | All Time1980-09-19 |
|---|---|---|---|---|---|---|---|
| Price | $ 4.47 | $ 5.41 | $ 21.50 | $ 208.50 | $ 1.38K | $ 132.5K | $ 916.77K |
| Return | — | -17.38% | -79.21% | -97.86% | -99.67% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 25M | -$ 62M | $ 146M |
| 2025 | $ 5M | $ 71M | $ 191M |
| 2024 | $ 0.00 | -$ 63M | $ 97M |
| 2023 | $ 3M | -$ 54M | $ 52M |
| 2022 | $ 1M | -$ 39M | $ 52M |
| 2021 | $ 3M | -$ 84M | $ 45M |
| 2020 | $ 10M | -$ 84M | $ 95M |
| 2019 | $ 0.00 | -$ 76M | $ 129M |
| 2018 | $ 2M | -$ 56M | $ 84M |
| 2017 | $ 837K | -$ 27M | $ 137M |
| 2016 | $ 889K | -$ 21M | $ 69M |
| 2015 | $ 1M | -$ 14M | $ 40M |
| 2014 | $ 925K | -$ 26M | $ 11M |
| 2013 | $ 2M | $ 4M | $ 424K |
| 2012 | $ 4M | -$ 10M | $ 396K |
| 2011 | $ 1M | -$ 2M | $ 2M |
| 2010 | $ 481K | -$ 7M | $ 7M |
| 2009 | $ 352K | -$ 17M | $ 607K |
| 2008 | $ 291K | -$ 31M | $ 2M |
| 2007 | $ 57K | -$ 21M | $ 6M |
| 2006 | -$ 12M | $ 4M | |
| 2005 | -$ 1M | $ 474K | |
| 2004 | $ 549K | -$ 10M | $ 2M |
| 2003 | $ 1M | -$ 6M | $ 2M |
| 2002 | $ 1M | -$ 9M | $ 9M |
| 2001 | $ 243K | -$ 6M | $ 20M |
| 2000 | $ 107K | -$ 5M | $ 25M |
| 1999 | $ 15K | -$ 3M | $ 900K |
| 1998 | $ 100K | -$ 3M | $ 1M |
| 1997 | $ 435K | -$ 4M | $ 438K |
| 1996 | $ 167K | -$ 11M | $ 4M |
| 1995 | $ 2M | $ 341K | $ 1M |
Abeona Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 10M to $ 5M and net income went from -$ 84M to $ 71M. Revenue increased in 3 of those 5 years; net income in 2.
Between 1995 and 2025, revenue grew from $ 2M to $ 5M and net income grew from $ 341K to $ 71M. Revenue increased in 18 of those 30 years; net income in 12.
Abeona Therapeutics Inc currently holds a 5-year HDB Score of 5.0 out of 10. How the HDB Score is calculated.
Membership
Continue ABEO’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,119 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
